SS&C Technologies (SSNC)

• Market cap: $17.9B
• 1 day: -6.12%
• 5 days: -3.58%
• 1 month: -12.75%
• 3 months: -9.34%
• 6 months: 3.78%
• Year to date: -3.66%
• 1 year: 18.56%
• 5 years: 38.80%
• 10 years: 133.13%
• Sector: Technology
• Industry: Software - Application

About: SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.

Employees: 26,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,183% more call options, than puts

Call options by funds: $61.2M | Put options by funds: $4.77M

27% more funds holding in top 10

Funds holding in top 10: 15 [Q3] → 19 (+4) [Q4]

1.85% more ownership

Funds ownership: 82.23% [Q3] → 84.07% (+1.85%) [Q4]

7% more repeat investments, than reductions

Existing positions increased: 238 | Existing positions reduced: 223

4% more capital invested

Capital invested by funds: $15B [Q3] → $15.6B (+$661M) [Q4]

3% less funds holding

Funds holding: 653 [Q3] → 632 (-21) [Q4]

10% less first-time investments, than exits

New positions opened: 80 | Existing positions closed: 89

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $86 18% upside
• Avg. target: $94 30% upside
• High target: $105 44% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

Raymond James Patrick O'Shaughnessy 47% 1-year accuracy 8 / 17 met price target	24% upside $90	Strong Buy Maintained	25 Apr 2025
Needham Mayank Tandon 35% 1-year accuracy 40 / 114 met price target	24% upside $90	Buy Maintained	25 Apr 2025
JP Morgan Alexei Gogolev 44% 1-year accuracy 11 / 25 met price target	18% upside $86	Neutral Downgraded	25 Apr 2025
DA Davidson Peter Heckmann 44% 1-year accuracy 22 / 50 met price target	38% upside $100	Buy Maintained	14 Apr 2025
RBC Capital Daniel Perlin 40% 1-year accuracy 20 / 50 met price target	32% upside $96	Outperform Maintained	7 Feb 2025